semaglutide and anorexia GLP-1 medications are changing the conversation around weight health, but what about eating disorder risk? Join us for our 30-minute May Micro Learning Session: The GLP-1 Era: Navigating Weight Loss Drugs 504: Adult Eating Disorders in

Conclusions SG achieved superior weight loss and metabolic improvements compared with semaglutide in this prospective 12-month study, though it was associated with a higher incidence of GERD symptoms

Since 1992, there have been over 100 published studies of BPC-157 and plenty of research in rats

Nevertheless, GLP-1 RAs have gastrointestinal adverse effects such as abdominal pain, constipation, diarrhea, nausea, and vomiting [7]

When the tally runs out, it's time to reconstitute a new vial don't wait for the vial to run dry and then realize you're out of BAC water or needles

Starting a GLP-1 to manage type 2 diabetes was associated with a higher chance of developing NAION within a year, based on a study using historical data of over 520,000 patients